nodes	percent_of_prediction	percent_of_DWPC	metapath
Nilotinib—MAPK8—cartilage tissue—otosclerosis	0.0689	0.15	CbGeAlD
Nilotinib—CA6—ear—otosclerosis	0.0486	0.106	CbGeAlD
Nilotinib—CA3—ear—otosclerosis	0.046	0.1	CbGeAlD
Nilotinib—MAPK8—Reelin signaling pathway—RELN—otosclerosis	0.0428	0.0788	CbGpPWpGaD
Nilotinib—PDGFRA—Osteoblast Signaling—COL1A1—otosclerosis	0.0272	0.0502	CbGpPWpGaD
Nilotinib—PDGFRB—Osteoblast Signaling—COL1A1—otosclerosis	0.0245	0.0452	CbGpPWpGaD
Nilotinib—ABL1—Lissencephaly gene (LIS1) in neuronal migration and development—RELN—otosclerosis	0.0235	0.0434	CbGpPWpGaD
Nilotinib—MAPK8—Nanoparticle-mediated activation of receptor signaling—COL1A1—otosclerosis	0.023	0.0424	CbGpPWpGaD
Nilotinib—MAPK11—VEGFR3 signaling in lymphatic endothelium—COL1A1—otosclerosis	0.02	0.037	CbGpPWpGaD
Nilotinib—MAPK11—Nanoparticle-mediated activation of receptor signaling—COL1A1—otosclerosis	0.0183	0.0338	CbGpPWpGaD
Nilotinib—CSF1R—Integrins in angiogenesis—COL1A1—otosclerosis	0.0173	0.0318	CbGpPWpGaD
Nilotinib—MAPK8—connective tissue—otosclerosis	0.0171	0.0374	CbGeAlD
Nilotinib—LYN—connective tissue—otosclerosis	0.0158	0.0345	CbGeAlD
Nilotinib—MAPK14—VEGFR3 signaling in lymphatic endothelium—COL1A1—otosclerosis	0.0143	0.0264	CbGpPWpGaD
Nilotinib—MAPK14—Nanoparticle-mediated activation of receptor signaling—COL1A1—otosclerosis	0.0131	0.0241	CbGpPWpGaD
Nilotinib—CDC42BPB—tendon—otosclerosis	0.013	0.0284	CbGeAlD
Nilotinib—MAPK8—tendon—otosclerosis	0.0118	0.0257	CbGeAlD
Nilotinib—CA3—connective tissue—otosclerosis	0.0117	0.0255	CbGeAlD
Nilotinib—MAPK14—connective tissue—otosclerosis	0.0109	0.0238	CbGeAlD
Nilotinib—MAP4K1—tendon—otosclerosis	0.0107	0.0234	CbGeAlD
Nilotinib—LCK—Inflammatory Response Pathway—COL1A1—otosclerosis	0.0107	0.0197	CbGpPWpGaD
Nilotinib—EPHB4—connective tissue—otosclerosis	0.0103	0.0225	CbGeAlD
Nilotinib—HCK—Focal Adhesion—RELN—otosclerosis	0.0102	0.0188	CbGpPWpGaD
Nilotinib—PDGFRB—Beta3 integrin cell surface interactions—COL1A1—otosclerosis	0.00999	0.0184	CbGpPWpGaD
Nilotinib—TEK—connective tissue—otosclerosis	0.00987	0.0216	CbGeAlD
Nilotinib—BRAF—tendon—otosclerosis	0.00979	0.0214	CbGeAlD
Nilotinib—MAPK8—Focal Adhesion—RELN—otosclerosis	0.00924	0.017	CbGpPWpGaD
Nilotinib—BLK—Focal Adhesion—RELN—otosclerosis	0.00924	0.017	CbGpPWpGaD
Nilotinib—FGR—Focal Adhesion—RELN—otosclerosis	0.00921	0.017	CbGpPWpGaD
Nilotinib—PDGFRA—connective tissue—otosclerosis	0.00894	0.0195	CbGeAlD
Nilotinib—HCK—tendon—otosclerosis	0.00892	0.0195	CbGeAlD
Nilotinib—ABL2—tendon—otosclerosis	0.00887	0.0194	CbGeAlD
Nilotinib—MAP2K5—Focal Adhesion—RELN—otosclerosis	0.00879	0.0162	CbGpPWpGaD
Nilotinib—EPHB2—Syndecan-2-mediated signaling events—TGFB1—otosclerosis	0.00833	0.0154	CbGpPWpGaD
Nilotinib—CA12—connective tissue—otosclerosis	0.00825	0.018	CbGeAlD
Nilotinib—EPHA4—tendon—otosclerosis	0.00811	0.0177	CbGeAlD
Nilotinib—CA3—tendon—otosclerosis	0.00801	0.0175	CbGeAlD
Nilotinib—CSF1R—connective tissue—otosclerosis	0.00787	0.0172	CbGeAlD
Nilotinib—CA9—tendon—otosclerosis	0.00767	0.0168	CbGeAlD
Nilotinib—HCK—Glypican 1 network—TGFB1—otosclerosis	0.00764	0.0141	CbGpPWpGaD
Nilotinib—MAPK14—tendon—otosclerosis	0.00748	0.0163	CbGeAlD
Nilotinib—FGR—tendon—otosclerosis	0.00745	0.0163	CbGeAlD
Nilotinib—BRAF—Focal Adhesion—RELN—otosclerosis	0.00729	0.0134	CbGpPWpGaD
Nilotinib—CA14—tendon—otosclerosis	0.00727	0.0159	CbGeAlD
Nilotinib—KIT—connective tissue—otosclerosis	0.00715	0.0156	CbGeAlD
Nilotinib—EPHB4—tendon—otosclerosis	0.00709	0.0155	CbGeAlD
Nilotinib—PDGFRB—connective tissue—otosclerosis	0.00698	0.0153	CbGeAlD
Nilotinib—EPHA2—tendon—otosclerosis	0.00695	0.0152	CbGeAlD
Nilotinib—BLK—Glypican 1 network—TGFB1—otosclerosis	0.00692	0.0128	CbGpPWpGaD
Nilotinib—MAPK14—IL4-mediated signaling events—COL1A1—otosclerosis	0.00692	0.0128	CbGpPWpGaD
Nilotinib—FGR—Glypican 1 network—TGFB1—otosclerosis	0.0069	0.0127	CbGpPWpGaD
Nilotinib—TEK—tendon—otosclerosis	0.00678	0.0148	CbGeAlD
Nilotinib—EPHB6—tendon—otosclerosis	0.00648	0.0142	CbGeAlD
Nilotinib—BRAF—Senescence and Autophagy in Cancer—COL1A1—otosclerosis	0.0063	0.0116	CbGpPWpGaD
Nilotinib—PDGFRA—Focal Adhesion—RELN—otosclerosis	0.00628	0.0116	CbGpPWpGaD
Nilotinib—ABL1—connective tissue—otosclerosis	0.00622	0.0136	CbGeAlD
Nilotinib—MAPK8—IL12 signaling mediated by STAT4—TGFB1—otosclerosis	0.00617	0.0114	CbGpPWpGaD
Nilotinib—PDGFRA—tendon—otosclerosis	0.00615	0.0134	CbGeAlD
Nilotinib—CSF1R—Differentiation Pathway—TGFB1—otosclerosis	0.00609	0.0112	CbGpPWpGaD
Nilotinib—PDGFRB—Focal Adhesion—RELN—otosclerosis	0.00566	0.0104	CbGpPWpGaD
Nilotinib—MAP2K5—tendon—otosclerosis	0.00554	0.0121	CbGeAlD
Nilotinib—HCK—Focal Adhesion—COL1A1—otosclerosis	0.00548	0.0101	CbGpPWpGaD
Nilotinib—MAP4K1—Cardiac Hypertrophic Response—TGFB1—otosclerosis	0.00546	0.0101	CbGpPWpGaD
Nilotinib—CSF1R—tendon—otosclerosis	0.00541	0.0118	CbGeAlD
Nilotinib—MAPK8—Syndecan-2-mediated signaling events—TGFB1—otosclerosis	0.00533	0.00984	CbGpPWpGaD
Nilotinib—BLK—Focal Adhesion—COL1A1—otosclerosis	0.00497	0.00916	CbGpPWpGaD
Nilotinib—MAPK8—Focal Adhesion—COL1A1—otosclerosis	0.00497	0.00916	CbGpPWpGaD
Nilotinib—FGR—Focal Adhesion—COL1A1—otosclerosis	0.00495	0.00913	CbGpPWpGaD
Nilotinib—PDGFRB—tendon—otosclerosis	0.0048	0.0105	CbGeAlD
Nilotinib—MAP2K5—Focal Adhesion—COL1A1—otosclerosis	0.00472	0.00871	CbGpPWpGaD
Nilotinib—HCK—IL-3 Signaling Pathway—TGFB1—otosclerosis	0.0046	0.00848	CbGpPWpGaD
Nilotinib—MAPK14—Senescence and Autophagy in Cancer—COL1A1—otosclerosis	0.00454	0.00837	CbGpPWpGaD
Nilotinib—ABL1—tendon—otosclerosis	0.00428	0.00935	CbGeAlD
Nilotinib—CA2—connective tissue—otosclerosis	0.00424	0.00926	CbGeAlD
Nilotinib—MAPK8—IL-3 Signaling Pathway—TGFB1—otosclerosis	0.00417	0.00769	CbGpPWpGaD
Nilotinib—LYN—Glypican 1 network—TGFB1—otosclerosis	0.00415	0.00766	CbGpPWpGaD
Nilotinib—BRAF—Focal Adhesion—COL1A1—otosclerosis	0.00392	0.00723	CbGpPWpGaD
Nilotinib—MAPK8—Cardiac Hypertrophic Response—TGFB1—otosclerosis	0.0038	0.00701	CbGpPWpGaD
Nilotinib—MAP4K1—TCR Signaling Pathway—TGFB1—otosclerosis	0.00369	0.0068	CbGpPWpGaD
Nilotinib—MAP2K5—Cardiac Hypertrophic Response—TGFB1—otosclerosis	0.00361	0.00666	CbGpPWpGaD
Nilotinib—CA4—tendon—otosclerosis	0.00351	0.00767	CbGeAlD
Nilotinib—LCK—Glypican 1 network—TGFB1—otosclerosis	0.0034	0.00627	CbGpPWpGaD
Nilotinib—PDGFRA—Focal Adhesion—COL1A1—otosclerosis	0.00338	0.00623	CbGpPWpGaD
Nilotinib—EPHA4—Spinal Cord Injury—TGFB1—otosclerosis	0.00333	0.00614	CbGpPWpGaD
Nilotinib—KIT—Differentiation Pathway—TGFB1—otosclerosis	0.00304	0.00561	CbGpPWpGaD
Nilotinib—PDGFRB—Focal Adhesion—COL1A1—otosclerosis	0.00304	0.00561	CbGpPWpGaD
Nilotinib—EPHA3—NRF2 pathway—TGFB1—otosclerosis	0.00294	0.00543	CbGpPWpGaD
Nilotinib—CA2—tendon—otosclerosis	0.00291	0.00636	CbGeAlD
Nilotinib—PDGFRB—Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling—TGFB1—otosclerosis	0.00289	0.00533	CbGpPWpGaD
Nilotinib—KIT—Cardiac Progenitor Differentiation—TGFB1—otosclerosis	0.00281	0.00519	CbGpPWpGaD
Nilotinib—MAP4K1—TGF-beta Signaling Pathway—TGFB1—otosclerosis	0.00271	0.005	CbGpPWpGaD
Nilotinib—MAPK8—MicroRNAs in cardiomyocyte hypertrophy—TGFB1—otosclerosis	0.00271	0.00499	CbGpPWpGaD
Nilotinib—PDGFRA—Cardiac Progenitor Differentiation—TGFB1—otosclerosis	0.00266	0.00491	CbGpPWpGaD
Nilotinib—MAP2K5—MicroRNAs in cardiomyocyte hypertrophy—TGFB1—otosclerosis	0.00258	0.00475	CbGpPWpGaD
Nilotinib—MAPK8—TCR Signaling Pathway—TGFB1—otosclerosis	0.00256	0.00473	CbGpPWpGaD
Nilotinib—MAPK8—Corticotropin-releasing hormone—TGFB1—otosclerosis	0.00252	0.00464	CbGpPWpGaD
Nilotinib—LYN—IL-3 Signaling Pathway—TGFB1—otosclerosis	0.0025	0.00461	CbGpPWpGaD
Nilotinib—UGT1A1—Aryl Hydrocarbon Receptor Pathway—TGFB1—otosclerosis	0.00246	0.00454	CbGpPWpGaD
Nilotinib—EPHA2—NRF2 pathway—TGFB1—otosclerosis	0.00229	0.00422	CbGpPWpGaD
Nilotinib—MAP4K1—MAPK Signaling Pathway—TGFB1—otosclerosis	0.00224	0.00412	CbGpPWpGaD
Nilotinib—MAPK14—Cardiac Progenitor Differentiation—TGFB1—otosclerosis	0.00223	0.00411	CbGpPWpGaD
Nilotinib—MAPK8—DNA Damage Response (only ATM dependent)—TGFB1—otosclerosis	0.0022	0.00405	CbGpPWpGaD
Nilotinib—MAPK14—Cardiac Hypertrophic Response—TGFB1—otosclerosis	0.00216	0.00399	CbGpPWpGaD
Nilotinib—BRAF—Corticotropin-releasing hormone—TGFB1—otosclerosis	0.00199	0.00367	CbGpPWpGaD
Nilotinib—PDGFRA—Allograft Rejection—TGFB1—otosclerosis	0.00193	0.00357	CbGpPWpGaD
Nilotinib—ABL1—Regulation of Telomerase—TGFB1—otosclerosis	0.00191	0.00353	CbGpPWpGaD
Nilotinib—MAPK8—TGF-beta Signaling Pathway—TGFB1—otosclerosis	0.00189	0.00348	CbGpPWpGaD
Nilotinib—BRAF—Senescence and Autophagy in Cancer—TGFB1—otosclerosis	0.00179	0.0033	CbGpPWpGaD
Nilotinib—MAPK8—MAPK Signaling Pathway—TGFB1—otosclerosis	0.00156	0.00287	CbGpPWpGaD
Nilotinib—MAPK14—MicroRNAs in cardiomyocyte hypertrophy—TGFB1—otosclerosis	0.00154	0.00284	CbGpPWpGaD
Nilotinib—MAP2K5—MAPK Signaling Pathway—TGFB1—otosclerosis	0.00148	0.00273	CbGpPWpGaD
Nilotinib—MAPK14—TCR Signaling Pathway—TGFB1—otosclerosis	0.00146	0.00269	CbGpPWpGaD
Nilotinib—MAPK14—Corticotropin-releasing hormone—TGFB1—otosclerosis	0.00143	0.00264	CbGpPWpGaD
Nilotinib—MAPK8—Integrated Pancreatic Cancer Pathway—TGFB1—otosclerosis	0.0014	0.00259	CbGpPWpGaD
Nilotinib—ABL1—Cell Cycle—TGFB1—otosclerosis	0.00138	0.00255	CbGpPWpGaD
Nilotinib—ABL1—DNA Damage Response (only ATM dependent)—TGFB1—otosclerosis	0.00131	0.00242	CbGpPWpGaD
Nilotinib—MAPK14—Senescence and Autophagy in Cancer—TGFB1—otosclerosis	0.00129	0.00238	CbGpPWpGaD
Nilotinib—EPHB3—Developmental Biology—TGFB1—otosclerosis	0.00125	0.0023	CbGpPWpGaD
Nilotinib—BRAF—MAPK Signaling Pathway—TGFB1—otosclerosis	0.00123	0.00226	CbGpPWpGaD
Nilotinib—EPHA3—Developmental Biology—TGFB1—otosclerosis	0.00111	0.00205	CbGpPWpGaD
Nilotinib—ABL2—Developmental Biology—TGFB1—otosclerosis	0.00111	0.00205	CbGpPWpGaD
Nilotinib—MAPK14—TGF-beta Signaling Pathway—TGFB1—otosclerosis	0.00107	0.00198	CbGpPWpGaD
Nilotinib—EPHA8—Developmental Biology—TGFB1—otosclerosis	0.00107	0.00197	CbGpPWpGaD
Nilotinib—EPHA4—Developmental Biology—TGFB1—otosclerosis	0.00106	0.00195	CbGpPWpGaD
Nilotinib—EPHB4—Developmental Biology—TGFB1—otosclerosis	0.00106	0.00195	CbGpPWpGaD
Nilotinib—EPHB2—Developmental Biology—TGFB1—otosclerosis	0.00103	0.00189	CbGpPWpGaD
Nilotinib—TEK—Hemostasis—TGFB1—otosclerosis	0.000996	0.00184	CbGpPWpGaD
Nilotinib—EPHB6—Developmental Biology—TGFB1—otosclerosis	0.000996	0.00184	CbGpPWpGaD
Nilotinib—UGT1A1—NRF2 pathway—TGFB1—otosclerosis	0.000977	0.0018	CbGpPWpGaD
Nilotinib—PDGFRA—Integrated Pancreatic Cancer Pathway—TGFB1—otosclerosis	0.000955	0.00176	CbGpPWpGaD
Nilotinib—PDGFRB—MAPK Signaling Pathway—TGFB1—otosclerosis	0.000953	0.00176	CbGpPWpGaD
Nilotinib—EPHA6—Developmental Biology—TGFB1—otosclerosis	0.000936	0.00173	CbGpPWpGaD
Nilotinib—MAPK14—MAPK Signaling Pathway—TGFB1—otosclerosis	0.000885	0.00163	CbGpPWpGaD
Nilotinib—EPHA2—Developmental Biology—TGFB1—otosclerosis	0.000863	0.00159	CbGpPWpGaD
Nilotinib—ABL1—Integrated Pancreatic Cancer Pathway—TGFB1—otosclerosis	0.000838	0.00155	CbGpPWpGaD
Nilotinib—MAPK14—Integrated Pancreatic Cancer Pathway—TGFB1—otosclerosis	0.000798	0.00147	CbGpPWpGaD
Nilotinib—LYN—Platelet activation, signaling and aggregation—TGFB1—otosclerosis	0.000749	0.00138	CbGpPWpGaD
Nilotinib—ABCB1—Allograft Rejection—TGFB1—otosclerosis	0.000733	0.00135	CbGpPWpGaD
Nilotinib—MAPK14—Platelet activation, signaling and aggregation—TGFB1—otosclerosis	0.00071	0.00131	CbGpPWpGaD
Nilotinib—FGR—Hemostasis—TGFB1—otosclerosis	0.000642	0.00118	CbGpPWpGaD
Nilotinib—LCK—Platelet activation, signaling and aggregation—TGFB1—otosclerosis	0.000614	0.00113	CbGpPWpGaD
Nilotinib—MAPK11—Developmental Biology—TGFB1—otosclerosis	0.000523	0.000964	CbGpPWpGaD
Nilotinib—LYN—Developmental Biology—TGFB1—otosclerosis	0.000394	0.000726	CbGpPWpGaD
Nilotinib—ABL1—Developmental Biology—TGFB1—otosclerosis	0.000392	0.000723	CbGpPWpGaD
Nilotinib—LYN—Hemostasis—TGFB1—otosclerosis	0.000386	0.000712	CbGpPWpGaD
Nilotinib—ABL1—Hemostasis—TGFB1—otosclerosis	0.000384	0.000709	CbGpPWpGaD
Nilotinib—MAPK14—Developmental Biology—TGFB1—otosclerosis	0.000373	0.000688	CbGpPWpGaD
Nilotinib—MAPK14—Hemostasis—TGFB1—otosclerosis	0.000366	0.000675	CbGpPWpGaD
Nilotinib—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—otosclerosis	0.000362	0.000667	CbGpPWpGaD
Nilotinib—HCK—Disease—TGFB1—otosclerosis	0.000344	0.000634	CbGpPWpGaD
Nilotinib—LCK—Hemostasis—TGFB1—otosclerosis	0.000317	0.000584	CbGpPWpGaD
Nilotinib—BRAF—Disease—TGFB1—otosclerosis	0.000246	0.000454	CbGpPWpGaD
Nilotinib—KIT—Disease—TGFB1—otosclerosis	0.000224	0.000413	CbGpPWpGaD
Nilotinib—MAPK8—Signaling Pathways—TGFB1—otosclerosis	0.000218	0.000403	CbGpPWpGaD
Nilotinib—PDGFRA—Disease—TGFB1—otosclerosis	0.000212	0.000391	CbGpPWpGaD
Nilotinib—MAP2K5—Signaling Pathways—TGFB1—otosclerosis	0.000208	0.000383	CbGpPWpGaD
Nilotinib—PDGFRB—Disease—TGFB1—otosclerosis	0.000191	0.000352	CbGpPWpGaD
Nilotinib—MAPK11—Signaling Pathways—TGFB1—otosclerosis	0.000174	0.000321	CbGpPWpGaD
Nilotinib—BRAF—Signaling Pathways—TGFB1—otosclerosis	0.000172	0.000318	CbGpPWpGaD
Nilotinib—KIT—Signaling Pathways—TGFB1—otosclerosis	0.000157	0.000289	CbGpPWpGaD
Nilotinib—LCK—Disease—TGFB1—otosclerosis	0.000153	0.000283	CbGpPWpGaD
Nilotinib—PDGFRA—Signaling Pathways—TGFB1—otosclerosis	0.000148	0.000274	CbGpPWpGaD
Nilotinib—PDGFRB—Signaling Pathways—TGFB1—otosclerosis	0.000134	0.000247	CbGpPWpGaD
Nilotinib—LYN—Signaling Pathways—TGFB1—otosclerosis	0.000131	0.000241	CbGpPWpGaD
Nilotinib—MAPK14—Signaling Pathways—TGFB1—otosclerosis	0.000124	0.000229	CbGpPWpGaD
Nilotinib—LCK—Signaling Pathways—TGFB1—otosclerosis	0.000107	0.000198	CbGpPWpGaD
